Arthur A. Hurwitz - Researcher Profile

Publications

2 shown

Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

Andrea van Elsas , Arthur A. Hurwitz , James P. Allison

We examined the effectiveness of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) blockade, alone or in combination with a granulocyte/macrophage colony-stimulating factor (...

1999 The Journal of Experimental Medicine 1010 citations

CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma

Arthur A. Hurwitz , Tina F.-Y. Yu , Dana R. Leach +1 more

Generation of a T cell-mediated antitumor response depends on T cell receptor engagement by major histocompatibility complex/antigen as well as CD28 ligation by B7. CTLA-4 is a ...

1998 Proceedings of the National Academy o... 373 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,383
Institution: Howard Hughes Medical Institute

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.